Federal Law Violations at Countrywide Home Loans and Bank of America

"qui tam" whistleblower attorney Brian LaBovick Palm Beach FloridaI have one question:  When will the prosecutions start?  What prosecutions?  Financial institutions across America are filled with high ranking officials who all participated in creating a culture and system of defrauding the American public and crashing the American economy with false and fraudulent loans!  Now the evidence is becoming overwhelming.  Instead of giving banks bail-out money, we should have asked the government to give them one-way tickets to jail.  Not all banks are bad, and not all bad loans are fraud.  But the huge amount of loans were issued on fraudulent signatures and false reports, and those fraudulent activities were caused and perpetrated by bank officials who have yet to be called to justice for their misdeeds.

Last month Eileen Foster appeared on a national news show to discuss the numerous federal law violations, which occurred at Countrywide Home Loans while she worked there.  Her testimony is proof that the financial debacle that went on at Countrywide and later Bank of America (BOA) was directly related to the fraud created by bank managers and workers to push through home loans.  The show was “60 Minutes,” and the link to that segment is below.  “60 Minutes” is the most trustworthy news program ever produced in TV history.  The fact that “60 Minutes” vetted Ms. Foster and found her to be credible and able to testify shows just how bad the corruption was at BOA and Countrywide Home Loans.

Factually, Foster worked at Countrywide starting in 2005 as a senior official.  After being promoted a number of times she eventually landed in the position of Senior Fraud Risk Manager.  This position put Foster as close to the epicenter of the financial collapse of the US Housing Market as anyone in history.  That role allowed Foster access to data that literally detailed a mountain of evidence that corporate employees had forged signatures of clients and barrowers, and altered or simply created fake documents to prove up fake assets or income and push through poorly-placed loans for people who couldn’t afford them, on property what was never worth the amount of the loan.  The amount of evidence was shocking; the degree of total fraud that was being done to manipulate the bank’s automated system of evaluating property value is scandalous as well. 

After working in this role for a few months, Ms. Foster realized that the fraud was not local to her city but was being perpetrated across the United States.  She found the same mind-blowing fraud in Miami, Las Vegas and Chicago.  She then found it in San Diego, Los Angeles and Cincinnati.  In other words, the fraud was being perpetrated across the entire business platform.  It had become de-facto business as usual and was no longer even viewed as fraud – it was just business!

Ms. Foster figured out that the company was allowing the employee relations department (ER) and their lending managers to collude and not report fraud to the bank’s normal internal reporting authority.  This was being done to keep the fraudulent activity under wraps and allowed the loan officers to meet inflated closing productivity numbers, which became the norm at the bank.  To keep the fraud going as long as possible, the company would allow management to retaliate against any employee who dared to question or “Whistleblow” on the banks fraud!

Prior to Countrywide merging with BOA, Ms. Foster filed a whistleblower complaint with the ER Division at Countrywide.  Countrywide never told BOA about Ms. Foster’s allegations.  Instead they did just the opposite.  Countrywide instructed their ER Department to investigate and bring a retaliatory action against Ms. Foster instead.  Now that is turning justice on its head.

Once BOA took over, Ms. Foster hoped she was going to a more honest and better run company.  BOA took foster in as a Senior Mortgage Fraud Investigator.  She accepted that position.  It was within that position that Ms. Foster finally learned that Countrywide was wrongfully investigating her.  They were trying to use that investigation to cover her complaints and create a reason, outside of needing to get rid of a whistleblower, to terminate her employment with BOA.  She found out that the company investigators were trying to bully Countrywide’s staff into giving negative testimony against Ms. Foster.  When BOA took over Countrywide’s investigation of Foster, they decided to ignore the overwhelming evidence that the investigation was simple retaliation and instead they terminated her employment.  They only did so after finding out that the US government regulators wanted to question her about Countrywide and BOA’s suspicious actions and reporting.

It wasn’t until Foster was terminated that she realized she needed to file a Sarbanes-Oxley Act (SOX) whistleblower complaint with the Occupational Safety & Health Administration (OSHA).  She did so and challenged the termination.  After a relatively short investigation, OSHA ruled on her complaint in September 2011.  They found that Foster was the victim of whistleblower retaliation.  They also found the retaliation was a violation of the Sarbanes Oxley employee protection guarantees.  The Department of Labor wrote in the Order that Foster must be reinstated in her position.  Further, BOA must pay her all her damages, including lost wages from the date of termination.  Bank of America did not like this ruling, so they are challenging the OSHA ruling and requesting a hearing.  We shall see what happens in the future.

Watch the “60 minutes” broadcast here.

If you have questions regarding any Whistleblower or Qui Tam Action, whether it is regarding the Sarbanes Oxley Act, the IRS Whistleblower Provisions or any Procurement or Health Care Fraud Qui Tam cases, please contact Brian LaBovick, Esq. at brian@labovick.com

2011: A Great Year for Whistleblowers

The Securities and Exchange Commission (SEC) has offered awards totaling hundreds of millions of dollars to employee whistleblowers who reported wrongdoing at their companies. Based on these whistleblowers’ information, 220 companies were brought to justice in 2011. The employee reports resulted in the federal government’s recovery of billions of dollars. These reports had been made over the past few years to the SEC and the companies’ internal compliance programs.

The list of companies forced to repay the federal government is an impressive one. It includes Dell Inc., Qwest Communications, Citigroup, UBS Financial Services, Johnson & Johnson, JP Morgan, Deloitte and Touché, and General Electric Company.

Click here for the full list of companies.

Qui Tam & Whistleblower Cases - Two billion dollar days for the US Attorney in a row!

Two billion dollar days for the US Attorney in a row! On January 6, Johnson & Johnson settled a U.S. probe into their anti-psychotic drug, Risperdal, for $1,000,000,000!  According to the Bloomberg news, J&J is going to resolve their long running dispute over Risperdal for a whopping $1 billion.  This settlement should cover all the damages each individual state has against J&J as well as the US government’s federal claims.  Given GlaxoSmithKlein just settled a claim for $3.2 billion, this settlement shouldn’t hurt J&J too badly.  Johnson & Johnson is the largest health product company in the world.  If Glaxo can pay $3 billion and that doesn’t count the civil claims against them for Avandia, certainly J&J is better off settling for $1 billion now.  The civil settlement may not have included a possible plea deal against Johnson for criminal penalties!  Now that is HARSH!  They are going to pay $1 billion and STILL pay a criminal price for their allegedly illegal sales practices.  The investigation against Risperdal has been going on since 2004.  The allegation is that the company was “off label” marketing the drug.  That means the drug was being marketed for uses that were not approved by the FDA.

In this case, the Whistleblowing Qui Tam Plaintiff could earn $150,000,000!

Interestingly, the civil cases against J&J for Risperdal have been varied, with two states finding for against the company while two other states found for the company.  We will see how this settlement effects the pending civil litigation in the future.

Avandia Cases Are Getting Ready to Settle or Explode

  Avandia cases are getting ready to settle or explode: 

GlaxoSmithKlien is ready to either pay out or be bleed to death in Avandia cases.  Recently they agreed to pay $3 Billion dollars to the Feds to avoid criminal and civil penalties and a trial. That case dealt, at least in part, with improper marketing of their defective drug, Avandia.  Over the past few years Plaintiff lawyers have gathered and filed over 30,000 Avandia injury cases in a multidistrict litigation.  This is because Avandia was supposed to control diabetes but was actually causing heart attacks.  Glaxo knew of the heart attack danger but covered it up.  Now Glaxo has settled over 10,000 of 30,000 cases in the MDL but is still fighting the remaining 20,000 claims.  So far, (above the $3 billion dollars they paid the government), Glaxo has paid about $700,000 in claims to injured patients. 

 

Now the court is getting impatient with Glaxo.  The Judge recently gave Glaxo 75 days to settle up at least 85% of the remaining cases or they would be set for trial.  It seems pretty obvious to all of us attorneys involved with Avandia, that after paying a $3 BILLION dollar fine and $700 MILLION in damages, Glaxo KNOWS Avandia was a bad drug and should settle the remaining cases.  

 

We will see that Glaxo actually does, but my bet is their bank account is a lot deeper then the remaining cases.  If they can pay the government and the first set of plaintiffs 3 billion 700 million dollars, they can settle up with the rest of the poor people they injured!

Defective Drug Companies Brought to Justice

whistleblower quit tam attorney palm beach floridaHEY WHISTLEBLOWERS! Are you interested in making a huge amount of money? I am betting there are plenty of drug company executives and sales people who are salivating at the possibility of turning their employer into the government for illegal marketing schemes. Over the past few years, the health and drug industry has been busted for multiple violations of federal law and paid huge money in Qui Tam whistleblower cases. 

 

The numbers on some of the cases are staggering.  In many health care provider cases, the payouts have been in the hundreds of millions of dollars to settle Qui Tam Whistleblower lawsuits.  When this happens, the Whistleblower is entitled to between 15% and 30% of the total funds recovered by the government. 

 

Recently, the mega drug maker GlaxoSmithKline agreed to pay $3 BILLION dollars to the Federal Government to avoid civil and criminal penalties which government prosecutors alleged were created when Glaxo orchestrated an illegal marketing scheme for a group of their most popular drugs.  The allegations included ripping off the Medicaid social funds program and promoting off label use for the drugs.  This is the largest settlement between a drug company and the government related to illegal marketing practices in US HISTORY!  It certainly beats the pants off the 2009 settlement Pfizer paid of $2.3 billion. 

 

This new agreement will close a long running chapter in Glaxos history. The US Attorney in Colorado and Massachusetts shared the investigation and prosecution of this mega case.  The charges included off-label promotion of Wellbutrin a well known anti-depressantl and included the Governments investigation into the often mentioned defective diabetes drug, Avandia.  You may remember Avandia being taken off the market last year by the FDA unless it was given as a drug of last resport!  This was because it was causing heart attacks instead of helping with diabetes, a somewhat consequential problem for Glaxo.  Avandia was promoted as a safe drug when Glaxo knew that Avandia was causing heart attacks and strokes. (see the case of In re Avandia Mktg., Sales Practices, and Prods. Liab. Litig., MDL No. 1871 (E.D. Pa. consolidated Feb. 28, 2008).) 

 

I am sure my Qui Tam clients are dreaming about being the Qui Tam Whistleblowers in a $3 BILLION DOLLAR pay out case.  Even at the statutory minimum payout of 15% the Whistleblower in this case should receive a nice check for $450,000,000.00!!!  Now that is a good day at the office!  The best part of it all is that a company that was breaking the law was brought to justice! 

LaBovick Law Group Sues Wells Fargo Bank for Terminating Whistleblower

PALM BEACH GARDENS, FLA. – When a Palm Beach County Wachovia Bank branch manager was reprimanded for not meeting exorbitant numbers, she investigated why her colleagues were. She found evidence of multiple violations of the “Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001” also known as the “Patriot Act.”

The LaBovick Law Group filed a civil litigation lawsuit in September alleging Wells Fargo, N.A. terminated an employee after she brought evidence of these "Patriot Act" violations to her superiors’ attention.

FULL PRESS RELEASE: Wells Fargo Bank Sued for Awareness of Violations of Patriot Act

Beware! Don't play with Qui Tam matches - You Can Get Burned!

Don't Play with Qui Tam Matches without being familiar with the statute - You will get burned!

This week the United States District Court (USDA) Sixth Circuit (6th Cir.) confirmed that the Plaintiff was liable for filing frivolous  Qui Tam Actions. In the case of Stalley v. Mt. States Health Alliance, 2011 U.S. App. LEXIS 13895, No. 10-5211/5212 (6th Cir. Jul. 8, 2011) the District Court for the Eastern District of Tennessee held that the Plaintiff had filed a frivolous Qui Tam action against the Defendant for failure to abide by the Medicare Secondary Payer Act (MSPA).

There is no actual authority to file a Qui Tam action for such a violation. However, on it's face, it would seem that breaching any portion of Medicare could straddle you Qui Tam liability. The court said no. To make matters worse, the court granted the Defendant sanctions against the Plaintiff in the amount of $276,589.00. Feeling confident that the MSPA should apply, the Plaintiff appealed.

UH OH! The USCA 6th said WE AGREE and AFFIRM the Sanctions. They also found that the sanctions should be held against plaintiff AND HIS COUNSEL!

The real lesson here is that an unfamiliar legal niche, such as Qui Tam, is a hard place to practice if you don't know the rules.

 

Three Miami Healthcare Workers convicted in $23M Medicare Fraud Scheme

A federal jury convicted three former health care workers for their roles in a $23 million HIV injection and infusion Medicare fraud scheme.

Jose Diaz, Lisandra Aguilera, and Estrella Rodriguez were all once employed by Metro Med of Hialeah Corp. The Metro Med clinic was allegedly a facility that helped HIV positive patients receive medically necessary infusions and injections. Many of these patients were Medicare beneficiaries. According to prosecutors, the fraudulent clinic charged for infusion therapies which were medically unnecessary or not provided at all.

In the operation of their fraudulent Medicare scheme, the group would provide kickbacks to patients who allowed them to use their Medicare number to fraudulently bill the system. In some instances the workers would falsify  the blood test results, making it appear as if certain injections and infusions were medically necessary. 

 

Continue Reading...

Two Florida Corporations Plead Guilty in $200 Million Medicare Fraud Scam

Two Florida Corporations, American Therapeutic Corporation (ATC) and Medlink Professional Management Group Inc., pleaded guilty to a Medicare fraud scheme of $200 million according to the Departments of Justice and Health and Human Services (HHS) announced.

ATC operated partial hospitalization programs (PHPs) in seven different locations throughout Florida. A PHP is a form of intensive treatment for severe mental illness. Medlink operated as a  "management company” for health care businesses. In reality, ATC and a related company, the American Sleep Institute (ASI), were Medlink’s only clients.

ATC and Medlink are each charged with conspiracy to commit health care fraud in a superseding indictment unsealed on Feb. 15, 2011. ATC is also charged with health care fraud and conspiracy to defraud the United States and to pay and receive illegal health care kickbacks.

Continue Reading...

Florida Radiology Clinic settles Qui Tam suit for $3 Million

Qui tam suit settled for $3 M by Florida Radiology Clinic

The U.S. Justice Department recently announced that a $3 million settlement had been reached in the case of a Florida radiology clinic that violated the Medicare False Claims Act.

The case was filed in 2009 after two physicians employed by the radiology clinic effectively blew the whistle on the violations and each became a relator in a qui tam suit.

Each relator claimed that the violations to the Medicare False Claims Act occurred during the period between 2000 and 2008. Essentially, the physicians alleged that Midtown Imaging, LLC and the former owners of the clinic, listed as Midtown Imaging, P.A. and PBC Medical Imaging, embarked upon improper financial relationships with other physicians and physicians groups.

 

Continue Reading...

The Impact of Supreme Court Decision on future False Claims Act cases

Supreme Court - False Claims Act and Schindler vs. Kirk

Did use of information obtained by the Freedom of Information Act (FOIA) just become a little less free? The recent Supreme Court Schindler Elevator Corporation vs. US ex rel. Kirk decision in a False Claims Act (FCA) case sheds some light on this topic. The Supreme Court ruled five to three that information obtained via the FOIA cannot be used for pursuing a claim under the FCA.

To understand the meaning of the Supreme Court's ruling and its potential impact on the role of whistleblowers, it may help to better understand the three parts of this case: The Freedom of Information Act, the False Claims Act, and the specific circumstances of the Schindler vs. Kirk case.

Freedom of Information Act
The Freedom of Information Act went into effect in 1967. It allows for disclosure, in full or in part, of information that has previously been unreleased by the federal government. Under the law, most documents produced by the federal government are available for scrutiny. Exclusions include anything that might threaten national security, hinder law enforcement efforts, or reveal commercial or financial trade secrets, amongst other things.

Continue Reading...

Florida Tax Preparer Convicted of Tax Fraud

IRS Tx FraudThere are few certainties in life, with death and taxes being among those certainties. For the former owner of First Premium Financial Services in Florida, prison time for tax fraud has recently become a reality.

Inuka Rhaheed, former owner of First Premium Financial Services, was once,  one of the Treasure Coast’s finest. As a former detective with the Fort Pierce Police Department, Rhaheed enjoyed a respected standing within his community. It’s easy to see why. People tend to trust law enforcement officers and former law enforcement officers.  Law enforcement officers are typically, honorable citizens with integrity that uphold the law, not bend it, like Rhaheed.

Clients who trusted Rhaheed, his partner, Jacqueline, and First Premium employee Wilens Bertrand, to lawfully prepare and file their taxes were got more than they bargained for. First Premium drew a sizable clientele, many being law enforcement officers. Since Rhaheed, was a former detective, it was assumed that he had integrity and was ethical in his tax preparation services.

 

Continue Reading...

$9 M Medicare Fraud Scam lands Patient Recruiter 77 Month Prison Term

Medicare Fraud scam lands Patient recruiter 77 month jail termFleeing to the Dominican Republic did not prove to be a fool-proof plan of escape for Reynel Betancourt. Betancourt, once an employee of Dearborn Medical Rehabilitation Center in Michigan, was sentenced to 77 months in prison for a scheme that defrauded Medicare of about $9 million.

Betancourt must pay approximately $6 million in restitution for his crimes against Medicare. As a rehabilitation center employee, Betancourt is said to have paid patients to sign fraudulent paperwork stating that they had received injections and other treatments that they did not actually receive. After receiving payment from Medicare, Betancourt laundered the money through phony corporations created for this express purpose.

After being captured in Miami and agreeing to a trial there instead of Michigan, Betancourt was charged with conspiracy to commit health care fraud and conspiracy to commit money laundering. He eventually plead guilty to the charges and was sentenced by U.S. District Court Judge Cecilia Altonaga in the Southern District of Florida on June 7, 2011.

 

Continue Reading...

Drug Giant UCB pays $34.4 M to settle illegal Epilepsy Drug Promotion

UCB pays $34.4 M to settle qui tam suitAll drug makers want consumers to believe that their product will be a miracle solution.  While many prescription medications can have a palpable impact on the lives of patients, such benefits can only be accrued when the medication is being used for the right condition. However, pharmaceutical companies are held accountable for the efficacy of their drugs and their advertising claims marketing  practices.

Recently, the drug maker, UCB has agreed to settle a qui tam lawsuit regarding the epilepsy drug Keppra,  for $34.4 million.   The North American Division of the Belgium pharmaceutical giant UCB admitted no wrong doing to the allegations, that Keppra, was marketed to treat other non-FDA approved conditions, such as headaches, migraines, and other pain based conditions.

Continue Reading...

Supreme Court Rules in favor of Drug Makers in False Claims Act Case

U.S. Supreme Court Healthcare facilities can’t bring False Claims Act lawsuits to enforce ceiling-price contracts between drug manufacturers and the Secretary of Health and Human Services, according to the United States Supreme Court in Astra USA v. Santa Clara County, No. 09-1273.

This was a huge win to the pharmaceutical industry and a major blow to health care facilities, since the ruling overturned an earlier  lower court decision in favor of the healthcare facilities.

The clinics involved in the Astra USA v. Santa Clara County case were from California. According to their case, brought under the California False Claims Act.  In a legal maneuvering, the pharmaceutical manufacturers had the case moved to federal court.

The heart of the legal issue is whether drug makers, were at fault in over charging Medicare and Medicaid more than the pre-determined caps for drugs that serve 340B entities medical facilities serving the poor.

The eight pharmaceutical manufacturers in the case included subsidiaries of Astra Zeneca, Sanofi-Aventis SA, Bayer AG, Takeda Pharmaceutical, Bristol Myers Squibb, Merck, Pfizer and GlaxoSmithKine.

Justice Ruth Bader Ginsburg, stated in her opinion that drug-pricing enforcement was solely the responsibility of the U.S. Department of Health and Human Services. "Recognizing the county's right to proceed in court could spawn a multitude of dispersed and uncoordinated lawsuits," Ginsburg said in a 10-page opinion. She said the risk of conflicting court rulings "would be substantial.

 

Continue Reading...